Park Ave Pharmacy is an authorized DME supplier for medicare equipments and products.
Park Ave Pharmacy is a Community/Retail Pharmacy in Paterson, New Jersey. This pharmacy is owned and operated by Park Ave Drugs Llc. It is located at 107 Park Ave, Paterson and it's customer support contact number is 973-928-8888. The authorized person of Park Ave Pharmacy is Abdulmajeed Hozien who is Pharmacist of the pharmacy and his contact number is 973-928-8888. Active license number of Park Ave Pharmacy is 28RS00710100 for Community/Retail Pharmacy in New Jersey. Park Ave Pharmacy accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Park Ave Pharmacy is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Park Ave Pharmacy type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Park Ave Pharmacy
Type:
Community/Retail Pharmacy
Location:
107 Park Ave, Paterson, New Jersey, 07501-2328
Phone:
973-928-8888
Fax:
973-742-0806
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Abdulmajeed Hozien
Position:
Pharmacist
Contact Number:
973-928-8888
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1497052245
NPI Enumeration Date:
14 Feb, 2011
NPI Last Update On:
04 Nov, 2020
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Park Ave Pharmacy are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
28RS00710100
New Jersey
Primary
Pharmacy
Secondary
Compounding Pharmacy
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
0276014
Medicaid
New Jersey
2128921
Other
Pk
Medicare Enrollment:
Park Ave Pharmacy is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
1355513870
O20111005000655
Park Ave Drugs Llc
DME SUPPLIER - PHARMACY
Products Available:
Park Ave Pharmacy has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Diabetic Shoes & Inserts: Prefabricated
Infrared Heating Pad Systems
Nebulizer Equipment & Supplies
Orthoses: Off-the-shelf
Ostomy Supplies
Surgical Dressings
Urological Supplies
Walkers
Wheelchair Seating/cushions
Wheelchairs & Accessories: Standard Manual
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
107 Park Ave, Paterson, New Jersey
Zip:
07501-2328
Phone Number:
305-928-8888
Fax Number:
973-742-0806
Patients can reach Park Ave Pharmacy at 107 Park Ave, Paterson, New Jersey or can call on customer care at 973-928-8888.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.